Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.67	50.59	57.28
Graham Fair Price	69.10	24.35	14.40
PEG	-90.35	0.08	0.79
Price/Book	4.96	1.50	1.43
Price/Cash Flow	-84.06	-43.44	-23.60
Prices/Earnings	-63.55	15.27	41.90
Price/Sales	-4.30	11.58	12.10
Price/FCF	-84.06	-43.44	-23.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.78	0.56	0.51
Operating Margin	22.31	0.26	0.21
ROA	206.57	< 0.005	< 0.005
ROE	< 0.005	0.02	187.94
ROIC	< 0.005	0.01	67.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	0.07	5.80
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-0.32	0.34	3.56
EPS QOQ	0.53	2.00	277.78
FCF QOQ	-0.52	0.43	-17.15
Revenue QOQ	-0.15	0.09	-36.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	95.87	98.92	3.18
Days Sales Outstanding (DSO)	69.37	60.46	-12.84
Inventory Turnover	0.94	0.91	-3.08
Debt/Capitalization	0.62	0.60	-2.33
Quick Ratio	0.11	0.17	53.43
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	32.85	32.74	-0.34
Cash	0.32	0.35	10.13
Capex	-3.65	-3.50	4.05
Free Cash Flow	-1.99	-1.13	43.17
Revenue	3.88	4.25	9.30
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.05	1.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	30.43	25.30	-16.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating